Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Immuron Limited ( (AU:IMC) ) has provided an announcement.
Immuron Limited has released its corporate governance statement for the financial year ending June 30, 2025, in compliance with ASX Listing Rules. The statement, available on their website, outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations. This disclosure is crucial for stakeholders as it provides transparency regarding the company’s governance practices and ensures accountability in its management and oversight processes.
More about Immuron Limited
Immuron Limited operates in the pharmaceutical industry, focusing on the development and commercialization of oral immunotherapy products for the treatment of gut-mediated diseases. The company is known for its innovative approach to addressing gastrointestinal health issues.
Average Trading Volume: 202,523
Technical Sentiment Signal: Sell
Current Market Cap: A$21.73M
Learn more about IMC stock on TipRanks’ Stock Analysis page.